Steroid pulse therapy in patients with encephalopathy associated with severe fever with thrombocytopenia syndrome

Shingen Nakamura, Momoyo Azuma, Tomoko Maruhashi, +12

Journal of Infection and Chemotherapy

ThrombopoiesisThrombosisSevere FeverHematologyThrombocytopenia Syndrome +4

TAK1 is a pivotal therapeutic target for tumor progression and bone destruction in myeloma

Jumpei Teramachi, Hirofumi Tenshin, Masahiro Hiasa, +16

Haematologica

Mm Tumor GrowthMm Cell AdhesionImmunologyTumor ProgressionCancer Biology +19

PD-L1 upregulation in myeloma cells by panobinostat in combination with interferon-γ

Masami Iwasa, Takeshi Harada, Asuka Oda, +13

Oncotarget

Human immunodeficiency virus-positive secondary syphilis mimicking cutaneous T-cell lymphoma

Michiko Yamashita, Yoshiyuki Fujii, Keiji Ozaki, +7

Diagnostic Pathology

Synergistic targeting of Sp1, a critical transcription factor for myeloma cell growth and survival, by panobinostat and proteasome inhibitors

Ariunzaya Bat‐Erdene, Hirokazu Miki, Asuko Oda, +14

Oncotarget

Proteasome InhibitorsSp1 Protein LevelsMedicineCritical Transcription FactorApoptosis +12

Unique anti‐myeloma activity by thiazolidine‐2,4‐dione compounds with Pim inhibiting activity

Shiro Fujii, Shingen Nakamura, Asuka Oda, +18

British Journal of Haematology

Combination with a Defucosylated Anti-HM1.24 Monoclonal Antibody plus Lenalidomide Induces Marked ADCC against Myeloma Cells and Their Progenitors

Takeshi Harada, Shuji Ozaki, Asuka Oda, +14

PLoS ONE

Immunomodulatory Drug LenalidomideHematological MalignancyAnti-hm1.24 Monoclonal AntibodyMalignant Blood DisorderImmunology +13

A vicious cycle between acid sensing and survival signaling in myeloma cells: acid-induced epigenetic alteration

Ryota Amachi, Masahiro Hiasa, Jumpei Teramachi, +19

Oncotarget

Acid SensingDr4 ExpressionMixed-phenotype Acute LeukemiaEpigenetic ChangeEpigenetics +20

TAK1 inhibition subverts the osteoclastogenic action of TRAIL while potentiating its antimyeloma effects

Hirofumi Tenshin, Jumpei Teramachi, Asuka Oda, +18

Blood Advances

Class 1 <scp>HDAC</scp> and <scp>HDAC</scp>6 inhibition inversely regulates <scp>CD</scp>38 induction in myeloma cells via interferon‐α and <scp>ATRA</scp>

Ariunzaya Bat‐Erdene, Shingen Nakamura, Asuka Oda, +17

British Journal of Haematology